Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Alimentary Pharmacology & Therapeutics
|
March 14, 2013
Meta-analysis: serological markers and the risk of acute and chronic pouchitis
S Singh, P K Sharma, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics
|
December 8, 2015
Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma - authors' reply
A Gupta, E V Loftus, K M De Felice, et al.
Mayo Clinic Proceedings
|
August 1, 1994
Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions
E V Loftus, G L Alexander, D A Ahlquist, et al.
Alimentary Pharmacology & Therapeutics
|
December 15, 2017
Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study
S Singh, N N Andersen, M Andersson, et al.
Inflammatory Bowel Diseases
|
January 4, 2013
Interactions between chronic liver disease and inflammatory bowel disease
E V Loftus, W J Sandborn, K D Lindor, et al.
Gastroenterology
|
April 21, 2001
Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine
D S Pardi, E V Loftus, W J Tremaine, et al.
Alimentary Pharmacology & Therapeutics
|
May 23, 2014
Letter: comparative efficacy of biological therapy in patients with ulcerative colitis
S Singh, S K Garg, Z Wang, et al.
Gastroenterology
|
July 27, 1999
Successful management of Crohn's disease of the ileoanal pouch with infliximab
E Ricart, R Panaccione, E V Loftus, et al.
The American Journal of Gastroenterology
|
March 31, 2001
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients
E Ricart, R Panaccione, E V Loftus, et al.
Inflammatory Bowel Diseases
|
May 25, 1999
Concurrent inflammatory bowel disease and myelodysplastic syndromes
G C Harewood, E V Loftus, A Tefferi, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Alimentary Pharmacology & Therapeutics
|
March 14, 2013
Meta-analysis: serological markers and the risk of acute and chronic pouchitis
S Singh, P K Sharma, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics
|
December 8, 2015
Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma - authors' reply
A Gupta, E V Loftus, K M De Felice, et al.
Mayo Clinic Proceedings
|
August 1, 1994
Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions
E V Loftus, G L Alexander, D A Ahlquist, et al.
Alimentary Pharmacology & Therapeutics
|
December 15, 2017
Comparison of infliximab with adalimumab in 827 biologic-naïve patients with Crohn's disease: a population-based Danish cohort study
S Singh, N N Andersen, M Andersson, et al.
Inflammatory Bowel Diseases
|
January 4, 2013
Interactions between chronic liver disease and inflammatory bowel disease
E V Loftus, W J Sandborn, K D Lindor, et al.
Gastroenterology
|
April 21, 2001
Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine
D S Pardi, E V Loftus, W J Tremaine, et al.
Alimentary Pharmacology & Therapeutics
|
May 23, 2014
Letter: comparative efficacy of biological therapy in patients with ulcerative colitis
S Singh, S K Garg, Z Wang, et al.
Gastroenterology
|
July 27, 1999
Successful management of Crohn's disease of the ileoanal pouch with infliximab
E Ricart, R Panaccione, E V Loftus, et al.
The American Journal of Gastroenterology
|
March 31, 2001
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients
E Ricart, R Panaccione, E V Loftus, et al.
Inflammatory Bowel Diseases
|
May 25, 1999
Concurrent inflammatory bowel disease and myelodysplastic syndromes
G C Harewood, E V Loftus, A Tefferi, et al.
Page
of 8